Published in Drug Alcohol Depend on September 26, 2006
Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med (2010) 3.84
The opioid-exposed newborn: assessment and pharmacologic management. J Opioid Manag (2009) 1.70
Prevention of mother-to-child transmission of human immunodeficiency virus among pregnant women using injecting drugs in Ukraine, 2000-10. Addiction (2011) 1.50
Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial. Pediatrics (2009) 1.33
Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. J Obstet Gynecol Neonatal Nurs (2012) 1.30
Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial. J Perinatol (2014) 1.28
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction (2012) 1.25
The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data. Curr Neuropharmacol (2008) 1.21
Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine. J Addict Dis (2010) 1.03
Neonatal abstinence syndrome--postnatal ward versus neonatal unit management. Eur J Pediatr (2009) 0.99
Neonatal abstinence syndrome: transitioning methadone-treated infants from an inpatient to an outpatient setting. J Perinatol (2011) 0.99
Pharmacological treatment of neonatal opiate withdrawal: between the devil and the deep blue sea. Int J Pediatr (2011) 0.96
Fetal neurobehavioral effects of exposure to methadone or buprenorphine. Neurotoxicol Teratol (2010) 0.94
Opioid dependent and pregnant: what are the best options for mothers and neonates? Obstet Gynecol Int (2012) 0.88
Anesthesia and analgesia in the NICU. Clin Perinatol (2012) 0.87
Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison. Addiction (2011) 0.85
HIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation. Glia (2012) 0.84
Pain management in newborns. Clin Perinatol (2014) 0.84
Neonatal abstinence syndrome: essentials for the practitioner. J Pediatr Pharmacol Ther (2014) 0.83
Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes. Ther Drug Monit (2011) 0.82
Drugs of choice for sedation and analgesia in the neonatal ICU. Clin Perinatol (2009) 0.80
(R)- and (S)-methadone and buprenorphine concentration ratios in maternal and umbilical cord plasma following chronic maintenance dosing in pregnancy. Br J Clin Pharmacol (2010) 0.79
Chronic in utero buprenorphine exposure causes prolonged respiratory effects in the guinea pig neonate. Neurotoxicol Teratol (2009) 0.77
Are male neonates more vulnerable to neonatal abstinence syndrome than female neonates? Gend Med (2011) 0.77
Time to initiation of treatment for neonatal abstinence syndrome in neonates exposed in utero to buprenorphine or methadone. Drug Alcohol Depend (2013) 0.76
Phenobarbital versus morphine in the management of neonatal abstinence syndrome, a randomized control trial. BMC Pediatr (2015) 0.75
Neonatal withdrawal syndrome, Michigan, 2000-2009. Am J Prev Med (2013) 0.75
Congenital nystagmus in two infants born from mothers exposed to methadone during pregnancy. Ital J Pediatr (2013) 0.75
Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med (2010) 3.84
Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction (2006) 2.04
Lithium in drinking water and suicide mortality. Br J Psychiatry (2011) 2.02
Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat (2008) 1.77
Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. Addiction (2005) 1.57
A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3. Hepatology (2008) 1.56
Influence of site differences between urban and rural American and Central European opioid-dependent pregnant women and neonatal outcome characteristics. Eur Addict Res (2012) 1.56
Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction (2008) 1.51
Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus? J Matern Fetal Neonatal Med (2012) 1.43
Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend (2003) 1.36
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction (2012) 1.25
Monocyte toll-like receptor 4 expression and LPS-induced cytokine production increase during gestational aging. Pediatr Res (2005) 1.21
A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes. Subst Abuse (2013) 1.16
Anxiety as a predictor of relapse in detoxified alcohol-dependent patients. Alcohol Alcohol (2002) 1.14
Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat (2010) 1.14
Maternal Opioid Treatment: Human Experimental Research (MOTHER)--approach, issues and lessons learned. Addiction (2012) 1.13
Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction (2003) 1.11
Evaluation of esthetic, functional, and quality-of-life outcome in adult cleft lip and palate patients. Cleft Palate Craniofac J (2005) 1.11
Cocaine use in Europe - a multi-centre study. Methodology and prevalence estimates. Eur Addict Res (2004) 1.10
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10
Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers. Implications for treatment. Eur Addict Res (2009) 1.07
Quality of life in patients receiving opioid maintenance therapy. A comparative study of slow-release morphine versus methadone treatment. Eur Addict Res (2008) 1.03
Cocaine use in Europe - a multi-centre study: patterns of use in different groups. Eur Addict Res (2004) 1.03
Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine. J Addict Dis (2010) 1.03
Substance abuse in patients with schizophrenia. Dialogues Clin Neurosci (2006) 1.02
Quality of life in long-term childhood cancer survivors and the relation of late effects and subjective well-being. Support Care Cancer (2004) 1.00
Multiple substance use among young males. Pharmacol Biochem Behav (2006) 0.98
Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women. Am J Addict (2010) 0.95
Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women. Hum Psychopharmacol (2011) 0.94
First-trimester fetal heart rate in mothers with opioid addiction. Addiction (2010) 0.94
Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER study. Am J Drug Alcohol Abuse (2009) 0.93
Psychologic implications of orthognathic surgery in patients with skeletal Class II or Class ill malocclusion. Int J Adult Orthodon Orthognath Surg (2002) 0.93
Psychopharmacologic management of opioid-dependent women during pregnancy. Am J Addict (2009) 0.92
No strong evidence for abnormal levels of dysfunctional attitudes, automatic thoughts, and emotional information-processing biases in remitted bipolar I affective disorder. Psychol Psychother (2008) 0.91
Age-related aspects of addiction. Gerontology (2012) 0.89
Small volume enemas do not accelerate meconium evacuation in very low birth weight infants. J Pediatr Gastroenterol Nutr (2007) 0.89
Retention rate and side effects in a prospective trial on hepatitis C treatment with pegylated interferon alpha-2a and ribavirin in opioid-dependent patients. Addict Biol (2009) 0.89
Opioid dependent and pregnant: what are the best options for mothers and neonates? Obstet Gynecol Int (2012) 0.88
Neonatal neurobehavior effects following buprenorphine versus methadone exposure. Addiction (2012) 0.88
Molecular cloning and heterologous expression of progesterone 5beta-reductase from Digitalis lanata Ehrh. Phytochemistry (2005) 0.88
Opioid addiction changes cerebral blood flow symmetry. Neuropsychobiology (2002) 0.87
Opioid dependence and pregnancy. Curr Opin Psychiatry (2008) 0.87
Office-based treatment in opioid dependence: a critical survey of prescription practices for opioid maintenance medications and concomitant benzodiazepines in Vienna, Austria. Eur Addict Res (2008) 0.86
Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison. Addiction (2011) 0.85
A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine. Nicotine Tob Res (2013) 0.85
The GOSLON yardstick in patients with unilateral cleft lip and palate: review of a Vienna sample. Cleft Palate Craniofac J (2008) 0.84
Maintenance therapy with synthetic opioids and driving aptitude. Eur Addict Res (2004) 0.84
[The relationship between tinnitus, personality, and depression]. Z Psychosom Med Psychother (2008) 0.84
Use of slow-release oral morphine for the treatment of opioid dependence. Eur Addict Res (2005) 0.83
3-D ultrasonographic imaging of the cerebral ventricular system in very low birth weight infants. Ultrasound Med Biol (2005) 0.83
Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users. World Psychiatry (2005) 0.83
Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder. Neuropsychopharmacology (2008) 0.82
[Cocaine abuse in Vienna and European cities--a multi-center study]. Wien Klin Wochenschr (2006) 0.81
Opioid plasma concentrations in methadone-and buprenorphine-maintained patients. Addict Biol (2005) 0.81
Mortality in opioid-maintained patients after release from an addiction clinic. Eur Addict Res (2008) 0.81
Buprenorphine maintenance: office-based treatment with addiction clinic support. Eur Addict Res (2004) 0.81
Glutamic acid in withdrawal and weaning in patients classified according to Cloninger's and Lesch's typologies. Alcohol Alcohol (2006) 0.81
[123I]-beta-CIT SPECT imaging shows reduced thalamus-hypothalamus serotonin transporter availability in 24 drug-free obsessive-compulsive checkers. Neuropsychopharmacology (2006) 0.81
Cognitive and emotion recognition deficits in obsessive-compulsive disorder. Psychiatry Res (2006) 0.80
Influence of peak and trough levels of opioid maintenance therapy on driving aptitude. Eur Addict Res (2007) 0.80
Breath alcohol level and plasma amino acids: a comparison between older and younger chronic alcohol-dependent patients. Alcohol Alcohol (2008) 0.80
Lessons learned from a comparison of evidence-based research in pregnant opioid-dependent women. Hum Psychopharmacol (2012) 0.80
Information preferences regarding cure rates and prognosis of Austrian patients with advanced lung cancer. Strahlenther Onkol (2015) 0.79
[Cognitive deficits in bipolar disorder]. Neuropsychiatr (2007) 0.79